2025-04-19 - Analysis Report
## Rocket Lab USA Inc (RKLB) Stock Analysis Report

**0. Key Figures Overview:**

* **Cumulative Return (RKLB):** 145.78%
* **Cumulative Return (VOO):** 14.32%
* **Return Difference (RKLB vs VOO):** 131.5%
* **Relative Return Difference:** 77.9% (Indicates RKLB significantly outperformed VOO historically, relative to its historical range of outperformance)
* **Current Closing Price:** $19.74
* **Market Risk Indicator (MRI):** 0.4244 (Medium Risk)


**1. Performance Comparison and Alpha/Beta Analysis:**

Rocket Lab USA Inc. is a provider of launch services and spacecraft components for the aerospace industry.  Compared to the S&P 500 (VOO), RKLB has significantly outperformed over the periods analyzed.  The substantial difference in cumulative returns highlights this outperformance.  However, the relative return difference emphasizes that while this outperformance is large, it's important to note that it falls within the historically observed range of outperformance for RKLB.

The Alpha/Beta analysis reveals a volatile stock with high beta values (greater than 1), indicating higher sensitivity to market movements than the overall market.  Negative alpha suggests underperformance relative to the market in some periods, while positive alpha signals outperformance. The dramatic shift in CAGR (Compound Annual Growth Rate) from negative to highly positive values indicates substantial fluctuations in performance across the years.  Specifically, it highlights that the more recent years (2022-2025) are showing substantial growth that wasn't evident in earlier periods.  The market capitalization has also shown significant growth.

| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2020-2022  | -39.0% | 70.8% | -37.0% | 1.7 |  |
| 2021-2023  | 0.0%  | 71.5% | -19.0% | 2.5 |  |
| 2022-2024  | 189.0% | 74.7% | -0.0% | 11.6 |  |
| 2023-2025  | 165.0% | 74.7% | -0.1% | 8.9 |  |


**2. Recent Price Movement:**

* **Closing Price:** $19.74
* **5-day Moving Average:** $19.91
* **20-day Moving Average:** $18.99
* **60-day Moving Average:** $22.28

The stock price is currently below its 5-day and 60-day moving averages, suggesting a short-term downward trend, while it's above the 20-day moving average, implying some support.  The recent price change of -$1.18 (approximately -6%) reflects a minor recent decline.


**3. Technical Indicators and Expected Return:**

* **Market Risk Indicator (MRI):** 0.4244 (Medium Risk)
* **RSI:** 53.78 (Slightly above neutral; neither overbought nor oversold)
* **PPO:** 1.92 (Positive, suggesting bullish momentum)
* **20-Day Relative Divergence Change:** +1.1 (Short-term upward trend)
* **Expected Return (2+ years):** -6.7% (Negative expected return compared to the current closing price, though long-term potential may exist considering the higher CAGR values from recent years).  This suggests that while the stock has dramatically outperformed the S&P 500 in the past,  current market sentiment predicts underperformance.  Note that this estimate doesn't directly account for the high beta and volatility demonstrated by RKLB.

The recent price drop (-$1.18) is a noteworthy change but doesn't indicate a dramatic event like a "crash" considering the relatively small magnitude of the change.


**4. Recent Earnings Analysis:**

| Date       | EPS   | Revenue       |
|------------|-------|---------------|
| 2024-11-12 | -0.1  | $0.10 B       |
| 2024-08-08 | -0.08 | $0.11 B       |
| 2024-05-06 | -0.09 | $0.09 B       |
| 2023-11-08 | -0.08 | $0.07 B       |
| 2024-11-12 | -0.08 | $0.07 B       | *(duplicate entry, possibly error in data)*

The company is currently reporting negative EPS, indicating losses. However, revenue is steadily increasing, although at a variable rate.  The inconsistency in the data (duplicate entry for 2024-11-12) necessitates a review for accuracy.


**5. Financial Information:**

**Revenue and Profitability:**

| Quarter | Revenue | Profit Margin |
|---------|----------|---------------|
| 2024-12-31 | $0.13B | 27.81% |
| 2024-09-30 | $0.10B | 26.71% |
| 2024-06-30 | $0.11B | 25.56% |
| 2024-03-31 | $0.09B | 26.06% |
| 2023-12-31 | $0.06B | 25.82% |

Revenue is showing a generally upward trend, and profit margins remain relatively consistent and healthy.

**Capital and Profitability:**

| Quarter | Equity | ROE |
|---------|---------|-----|
| 2024-12-31 | $0.38B | -13.69% |
| 2024-09-30 | $0.42B | -12.37% |
| 2024-06-30 | $0.46B | -9.15% |
| 2024-03-31 | $0.48B | -9.24% |
| 2023-12-31 | $0.55B | -9.11% |


Equity is decreasing, and the negative ROE indicates that the company is not yet generating returns on its equity.  This is a point of concern for long-term investors.


**6. Overall Analysis:**

RKLB has shown remarkable historical outperformance compared to the S&P 500.  However, recent data reveals a negative expected return (-6.7%), which is at odds with the prior periods of strong growth.  While revenue is growing and profit margins are healthy, negative EPS and ROE raise concerns about the company's profitability and long-term sustainability. The high beta suggests significant market risk.  Further investigation into the accuracy of the provided data (specifically the duplicate earnings entry) is crucial before drawing definitive conclusions.  The current price action suggests a short-term bearish trend, but the long-term outlook is highly uncertain and dependent on the company's ability to achieve profitability and sustain its revenue growth.  Investors should carefully weigh the high growth potential against the substantial risk before investing.
